Shalender Bhasin

Apr 1, 2024 | medscape.com | Shalender Bhasin

closePlease confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Prof Shalender Bhasin reviews the TRAVERSE trial, a critical evaluation of the effects of testosterone replacement therapy (TRT) on prostate health in older men. This trial addresses key questions in the context of TRT, investigating its effects on prostate cancer incidence and other prostate-related outcomes.

Mar 1, 2024 | healio.com | Michael Monostra |Richard Smith |T. Hugh Jones |Shalender Bhasin

T. Hugh Jones, BSc, MBChB, MD, FRCP The primary outcome of the TRAVERSE study was reported in the New England Journal of Medicine last year. Testosterone therapy was not associated with an increased risk for a major adverse cardiovascular event compared with placebo in this large study that included men with either known CVD or high CV risk, which comprised approximately 70% of men with diabetes.

Feb 5, 2024 | jamanetwork.com | Shalender Bhasin |A. Michael Lincoff |Steven Nissen

Key PointsQuestion  Does testosterone replacement therapy (TRT) prevent progression from prediabetes to diabetes or induce glycemic remission in middle-aged and older men with hypogonadism?

Feb 5, 2024 | jamanetwork.com | Kenneth E. Covinsky |Shalender Bhasin

Testosterone Replacement Therapy and Diabetes in Men With Hypogonadism Testosterone and Progression From Prediabetes to Diabetes in Men With Hypogonadism Shalender Bhasin, MB, BS; A. Michael Lincoff, MD; Steven E. Nissen, MD; Kathleen Wannemuehler, PhD; Marie E. McDonnell, MD; Anne L. Peters, MD; Nader Khan, MD; Michael C. Snabes, MD, PhD; Xue Li, PhD; Geng Li, MS; Kevin Buhr, PhD; Karol M. Pencina, PhD; Thomas G.

Nov 13, 2023 | healio.com | Michael Monostra |Richard Smith |Shalender Bhasin

You've successfully added Endocrinology: Hormone Therapy to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Men with anemia were more likely to have correction of their condition with testosterone therapy vs. placebo.